Skip to Content

Xenon Pharmaceuticals Inc

Rating as of

Company Profile

Business Description

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including the rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901 and XEN496 for Epilepsy, XEN007 for Orphan neurological and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out through Canada.

Contact
200-3650 Gilmore Way
Burnaby, BC, V5G 4W8, Canada
T +1 604 484-3300
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Mar 31, 2020
Fiscal Year End Dec 31, 2020
Stock Type
Employees 104